{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:02:34Z","timestamp":1789981354222,"version":"4.0.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00210-026-05556-7","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T02:44:40Z","timestamp":1781923480000},"page":"19173-19186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disproportionality analysis of drug-associated tinnitus safety signals: a 43-year pharmacovigilance study"],"prefix":"10.1007","volume":"399","author":[{"given":"Nagalakshmi","family":"Narasimhaswamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyamala","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4974-1921","authenticated-orcid":false,"given":"Basavaraj","family":"Poojar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"issue":"1","key":"5556_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/bcpt.12640","volume":"120","author":"G Alvan","year":"2017","unstructured":"Alvan G, Berninger E, Gustafsson LL, Karlsson KK, Paintaud G, Wakelkamp M (2017) Concentration\u2013response relationship of hearing impairment caused by quinine and salicylate: pharmacological similarities but different molecular mechanisms. Basic Clin Pharmacol Toxicol 120(1):5\u201313. https:\/\/doi.org\/10.1111\/bcpt.12640","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"5556_CR2","doi-asserted-by":"publisher","unstructured":"Baldo P, Doree C, Molin P, McFerran D, Cecco S (2012) Antidepressants for patients with tinnitus. Cochrane database of systematic reviews. (9). https:\/\/doi.org\/10.1002\/14651858.cd003853.pub2","DOI":"10.1002\/14651858.cd003853.pub2"},{"issue":"3","key":"5556_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.amjmed.2009.08.006","volume":"123","author":"SG Curhan","year":"2010","unstructured":"Curhan SG, Eavey R, Shargorodsky J, Curhan GC (2010) Analgesic use and the risk of hearing loss in men. Am J Med 123(3):231\u20137. https:\/\/doi.org\/10.1016\/j.amjmed.2009.08.006","journal-title":"Am J Med"},{"issue":"14","key":"5556_CR4","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1007\/s11606-021-07349-5","volume":"37","author":"SG Curhan","year":"2022","unstructured":"Curhan SG, Glicksman J, Wang M, Eavey RD, Curhan GC (2022) Longitudinal study of analgesic use and risk of incident persistent tinnitus. J Gen Intern Med 37(14):3653\u201362. https:\/\/doi.org\/10.1007\/s11606-021-07349-5","journal-title":"J Gen Intern Med"},{"issue":"5","key":"5556_CR5","doi-asserted-by":"publisher","first-page":"102640","DOI":"10.1016\/j.amjoto.2020.102640","volume":"42","author":"P De Luca","year":"2021","unstructured":"De Luca P, Scarpa A, De Bonis E, Cavaliere M, Viola P, Gioacchini FM, Ralli M, Ettore C, Claudia C (2021) Chloroquine and hydroxychloroquine ototoxicity; potential implications for SARS-CoV-2 treatment. A brief review of the literature. Am J Otolaryngol 42(5):102640. https:\/\/doi.org\/10.1016\/j.amjoto.2020.102640","journal-title":"Am J Otolaryngol"},{"issue":"3","key":"5556_CR6","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/00031305.1999.10474456","volume":"53","author":"W DuMouchel","year":"1999","unstructured":"DuMouchel W (1999) Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. Am Stat 53(3):177\u201390. https:\/\/doi.org\/10.1080\/00031305.1999.10474456","journal-title":"Am Stat"},{"key":"5556_CR7","unstructured":"European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) (n.d.)\u00a0ENCePP guide on methodological standards in pharmacoepidemiology [Internet]. Amsterdam: European Medicines Agency; [cited 2026 May 16]. Available from: https:\/\/encepp.europa.eu\/encepp-toolkit\/methodological-guide_en"},{"issue":"1","key":"5556_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000013861","volume":"5","author":"A Forge","year":"2000","unstructured":"Forge A, Schacht J (2000) Aminoglycoside antibiotics. Audiol Neurotol 5(1):3\u201322. https:\/\/doi.org\/10.1159\/000013861","journal-title":"Audiol Neurotol"},{"key":"5556_CR9","doi-asserted-by":"publisher","first-page":"1488725","DOI":"10.3389\/fphar.2024.1488725","volume":"15","author":"M Fusaroli","year":"2024","unstructured":"Fusaroli M, Salvo F, Khouri C, Raschi E (2024) The reporting of disproportionality analysis in pharmacovigilance: spotlight on the READUS-PV guideline. Front Pharmacol 15:1488725. https:\/\/doi.org\/10.3389\/fphar.2024.1488725","journal-title":"Front Pharmacol"},{"key":"5556_CR10","doi-asserted-by":"publisher","unstructured":"Green K, Drvota V, Vesterqvist O (1989) Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol). Prostaglandins 37(3):311\u2013315. https:\/\/doi.org\/10.1016\/0090-6980(89)90001-4","DOI":"10.1016\/0090-6980(89)90001-4"},{"key":"5556_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fnsys.2012.00012","volume":"6","author":"MJ Guitton","year":"2012","unstructured":"Guitton MJ (2012) Tinnitus: pathology of synaptic plasticity at the cellular and system levels. Front Syst Neurosci 6:12. https:\/\/doi.org\/10.3389\/fnsys.2012.00012","journal-title":"Front Syst Neurosci"},{"key":"5556_CR12","doi-asserted-by":"publisher","unstructured":"Hauben M, Bate A (2009) Decision support methods for the detection of adverse events in post-marketing data. Drug Discov Today 14(7\u20138):343\u201357\u00a0https:\/\/doi.org\/10.1016\/j.drudis.2008.12.012","DOI":"10.1016\/j.drudis.2008.12.012"},{"issue":"5","key":"5556_CR13","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","volume":"29","author":"L Hazell","year":"2006","unstructured":"Hazell L, Shakir SA (2006) Under-reporting of adverse drug reactions. Drug Saf 29(5):385\u2013396. https:\/\/doi.org\/10.2165\/00002018-200629050-00003","journal-title":"Drug Saf"},{"key":"5556_CR14","unstructured":"International Conference on Harmonisation (2004) ICH Topic E2E: Pharmacovigilance Planning. CPMP\/ICH\/5716\/03. London: European Medicines Agency. Available from: https:\/\/www.ema.europa.eu\/en\/ich-e2e-pharmacovigilance-planning-pvp-scientific-guideline.\u00a0Accessed 26 Feb 2026"},{"issue":"3","key":"5556_CR15","doi-asserted-by":"publisher","first-page":"104611","DOI":"10.1016\/j.amjoto.2025.104611","volume":"46","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, Liu Q, Ding Y, Sun Y (2025) Systematic review and meta-analysis of the correlation between tinnitus and mental health. Am J Otolaryngol 46(3):104611","journal-title":"Am J Otolaryngol"},{"issue":"9","key":"5556_CR16","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1001\/jamaneurol.2022.2189","volume":"79","author":"CM Jarach","year":"2022","unstructured":"Jarach CM, Lugo A, Scala M, Van Den Brandt PA, Cederroth CR, Odone A, Garavello W, Schlee W, Langguth B, Gallus S (2022) Global prevalence and incidence of tinnitus: a systematic review and meta-analysis. JAMA Neurol 79(9):888\u2013900","journal-title":"JAMA Neurol"},{"key":"5556_CR17","doi-asserted-by":"publisher","first-page":"661740","DOI":"10.3389\/fneur.2021.661740","volume":"12","author":"M Jozefowicz-Korczynska","year":"2021","unstructured":"Jozefowicz-Korczynska M, Pajor A, Lucas Grzelczyk W (2021) The ototoxicity of antimalarial drugs\u2014a state of the art review. Front Neurol 12:661740. https:\/\/doi.org\/10.3389\/fneur.2021.661740","journal-title":"Front Neurol"},{"issue":"4","key":"5556_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-081990","volume":"14","author":"R Kiguba","year":"2024","unstructured":"Kiguba R, Isabirye G, Mayengo J, Owiny J, Tregunno P, Harrison K, Pirmohamed M, Ndagije HB (2024) Navigating duplication in pharmacovigilance databases: a scoping review. BMJ Open 14(4):e081990. https:\/\/doi.org\/10.1136\/bmjopen-2023-081990","journal-title":"BMJ Open"},{"issue":"6","key":"5556_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare9060779","volume":"9","author":"SH Kim","year":"2021","unstructured":"Kim SH, Kim D, Lee JM, Lee SK, Kang HJ, Yeo SG (2021) Review of pharmacotherapy for tinnitus. Healthcare (Basel) 9(6):779. https:\/\/doi.org\/10.3390\/healthcare9060779","journal-title":"Healthcare (Basel)"},{"key":"5556_CR20","doi-asserted-by":"publisher","first-page":"1480994","DOI":"10.3389\/fphar.2024.1480994","volume":"15","author":"B Li","year":"2024","unstructured":"Li B, Hu X, Yue Z (2024) Drug-induced hearing disorders: a disproportionality analysis of the FAERS database. Front Pharmacol 15:1480994. https:\/\/doi.org\/10.3389\/fphar.2024.1480994","journal-title":"Front Pharmacol"},{"issue":"1","key":"5556_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/aje\/kww154","volume":"185","author":"BM Lin","year":"2017","unstructured":"Lin BM, Curhan SG, Wang M, Eavey R, Stankovic KM, Curhan GC (2017) Duration of analgesic use and risk of hearing loss in women. Am J Epidemiol 185(1):40\u20137. https:\/\/doi.org\/10.1093\/aje\/kww154","journal-title":"Am J Epidemiol"},{"key":"5556_CR22","doi-asserted-by":"publisher","first-page":"1532461","DOI":"10.3389\/fphar.2025.1532461","volume":"16","author":"J Liu","year":"2025","unstructured":"Liu J, Tan J, Xiao Q, Bai Y, Chang E, Su C, Wei Y, Zhong H, Wei W (2025) Drug-associated hearing impairment in children: a disproportionality analysis of the FDA adverse event reporting system. Front Pharmacol 16:1532461. https:\/\/doi.org\/10.3389\/fphar.2025.1532461","journal-title":"Front Pharmacol"},{"issue":"2","key":"5556_CR23","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1542\/peds.2008-0185","volume":"123","author":"AD Mosholder","year":"2009","unstructured":"Mosholder AD, Gelperin K, Hammad TA, Phelan K, Johann-Liang R (2009) Hallucinations and other psychotic symptoms associated with the use of attention-deficit\/hyperactivity disorder drugs in children. Pediatrics 123(2):611\u20136. https:\/\/doi.org\/10.1542\/peds.2008-0185","journal-title":"Pediatrics"},{"issue":"21","key":"5556_CR24","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.1002\/sim.2473","volume":"25","author":"GN Nor\u00e9n","year":"2006","unstructured":"Nor\u00e9n GN, Bate A, Orre R, Edwards IR (2006) Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events. Stat Med 25(21):3740\u201357. https:\/\/doi.org\/10.1002\/sim.2473","journal-title":"Stat Med"},{"issue":"4","key":"5556_CR25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/cpt.603","volume":"101","author":"R Parfitt","year":"2017","unstructured":"Parfitt R, Ciarimboli G (2017) Drug\u2010induced ototoxicity: mechanisms, pharmacogenetics, and protective strategies. Clin Pharmacol Ther 101(4):491\u2013500. https:\/\/doi.org\/10.1002\/cpt.603","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"5556_CR26","doi-asserted-by":"publisher","first-page":"9028","DOI":"10.1097\/MS9.0000000000004230","volume":"87","author":"N Pathak","year":"2025","unstructured":"Pathak N, Chhetri SK, Singh DK, Mishra SK (2025) Bupropion-induced tinnitus after dose escalation: a rare and reversible adverse effect\u2013a case report. Ann Med Surg (Lond) 87(12):9028\u201330. https:\/\/doi.org\/10.1097\/MS9.0000000000004230","journal-title":"Ann Med Surg (Lond)"},{"key":"5556_CR27","doi-asserted-by":"publisher","unstructured":"Poluzzi E, Raschi E, Piccinni C, De Ponti F (2012) Data mining techniques in pharmacovigilance: analysis of the publicly accessible FDA adverse event reporting system (AERS). InData mining applications in engineering and medicine. IntechOpen. https:\/\/doi.org\/10.5772\/50095","DOI":"10.5772\/50095"},{"key":"5556_CR28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fpubh.2020.00252","volume":"8","author":"P Prayuenyong","year":"2020","unstructured":"Prayuenyong P, Kasbekar AV, Baguley DM (2020) Clinical implications of chloroquine and hydroxychloroquine ototoxicity for COVID-19 treatment: a mini-review. Front Public Health 8:252. https:\/\/doi.org\/10.3389\/fpubh.2020.00252","journal-title":"Front Public Health"},{"issue":"10","key":"5556_CR29","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3390\/ph16101353","volume":"16","author":"S Rivetti","year":"2023","unstructured":"Rivetti S, Romano A, Mastrangelo S, Attin\u00e0 G, Maurizi P, Ruggiero A (2023) Aminoglycosides-related ototoxicity: mechanisms, risk factors, and prevention in pediatric patients. Pharmaceuticals (Basel) 16(10):1353. https:\/\/doi.org\/10.3390\/ph16101353","journal-title":"Pharmaceuticals (Basel)"},{"key":"5556_CR30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/s0079-6123(07)66024-5","volume":"166","author":"S Robinson","year":"2007","unstructured":"Robinson S (2007) Antidepressants for treatment of tinnitus. Prog Brain Res 166:263\u201371. https:\/\/doi.org\/10.1016\/s0079-6123(07)66024-5","journal-title":"Prog Brain Res"},{"issue":"3","key":"5556_CR31","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1620\/tjem.219.177","volume":"219","author":"LP Rybak","year":"2009","unstructured":"Rybak LP, Mukherjea D, Jajoo S, Ramkumar V (2009) Cisplatin ototoxicity and protection: clinical and experimental studies. Tohoku J Exp Med 219(3):177\u201386","journal-title":"Tohoku J Exp Med"},{"issue":"1","key":"5556_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12012-010-9096-5","volume":"11","author":"J Rybka","year":"2011","unstructured":"Rybka J, Kupczyk D, K\u0119dziora-Kornatowska K, Motyl J, Czuczejko J, Szewczyk-Golec K, Kozakiewicz M, Pawluk H, Carvalho LA, K\u0119dziora J (2011) Glutathione-related antioxidant defense system in elderly patients treated for hypertension. Cardiovasc Toxicol 11(1):1\u20139. https:\/\/doi.org\/10.1007\/s12012-010-9096-5","journal-title":"Cardiovasc Toxicol"},{"key":"5556_CR33","doi-asserted-by":"publisher","unstructured":"Rybak LP, Ramkumar V, Mukherjea D (2021) Ototoxicity of non-aminoglycoside antibiotics. Front Neurol 9(12):652674.\u00a0https:\/\/doi.org\/10.3389\/fneur.2021.65267417\u00a0","DOI":"10.3389\/fneur.2021.65267417"},{"key":"5556_CR34","doi-asserted-by":"publisher","unstructured":"Salvi R, Auerbach BD, Lau C, Chen YC, Manohar S, Liu X, Ding D, Chen GD (2020) Functional neuroanatomy of salicylate-and noise-induced tinnitus and hyperacusis. In The Behavioral Neuroscience of Tinnitus (pp. 133\u2013160). Cham: Springer International Publishing. https:\/\/doi.org\/10.1007\/7854_2020_156","DOI":"10.1007\/7854_2020_156"},{"issue":"3S","key":"5556_CR35","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1044\/2020_AJA-20-00023","volume":"30","author":"R Salvi","year":"2021","unstructured":"Salvi R, Radziwon K, Manohar S, Auerbach B, Ding D, Liu X, Lau C, Chen YC, Chen GD (2021) Neural mechanisms of tinnitus and hyperacusis in acute drug-induced ototoxicity. Am J Audiol 30(3S):901\u201315. https:\/\/doi.org\/10.1044\/2020_AJA-20-00023","journal-title":"Am J Audiol"},{"issue":"7","key":"5556_CR36","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7150\/ijms.6048","volume":"10","author":"T Sakaeda","year":"2013","unstructured":"Sakaeda T, Tamon A, Kadoyama K, Okuno Y (2013) Data mining of the public version of the FDA adverse event reporting system. Int J Med Sci 10(7):796. https:\/\/doi.org\/10.7150\/ijms.6048","journal-title":"Int J Med Sci"},{"issue":"11","key":"5556_CR37","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1002\/ar.22578","volume":"295","author":"J Schacht","year":"2012","unstructured":"Schacht J, Talaska AE, Rybak LP (2012) Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention. Anat Rec 295(11):1837\u201350","journal-title":"Anat Rec"},{"issue":"5","key":"5556_CR38","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0030-6665(20)30766-0","volume":"26","author":"VG Schweitzer","year":"1993","unstructured":"Schweitzer VG (1993) Ototoxicity of chemotherapeutic agents. Otolaryngol Clin North Am 26(5):759\u201389","journal-title":"Otolaryngol Clin North Am"},{"key":"5556_CR39","doi-asserted-by":"publisher","unstructured":"Seligmann H, Podoshin L, Ben-David J, Fradis M, Goldsher M (1996) Drug-induced tinnitus and other hearing disorders. Drug Saf 14(3):198\u2013212. https:\/\/doi.org\/10.2165\/00002018-199614030-00006","DOI":"10.2165\/00002018-199614030-00006"},{"issue":"4","key":"5556_CR40","doi-asserted-by":"publisher","first-page":"707","DOI":"10.3109\/00016489109138403","volume":"111","author":"WE Shehata","year":"1991","unstructured":"Shehata WE, Brownell WE, Dieler R (1991) Effects of salicylate on shape, electromotility and membrane characteristics of isolated outer hair cells from guinea pig cochlea. Acta Otolaryngol 111(4):707\u201318. https:\/\/doi.org\/10.3109\/00016489109138403","journal-title":"Acta Otolaryngol"},{"key":"5556_CR41","unstructured":"Sheppard A, Hayes SH, Chen GD, Ralli M, Salvi R (2014) Review of salicylate-induced hearing loss, neurotoxicity, tinnitus and neuropathophysiology. Acta Otorhinolaryngologica Italica 34(2):79"},{"issue":"2","key":"5556_CR42","first-page":"119","volume":"15","author":"A Shulman","year":"2009","unstructured":"Shulman A, Strashun AM (2009) Fluid dynamics vascular theory of brain and inner-ear function in traumatic brain injury: a translational hypothesis for diagnosis and treatment. Int Tinnitus J 15(2):119\u201329","journal-title":"Int Tinnitus J"},{"key":"5556_CR43","doi-asserted-by":"publisher","unstructured":"Shulman A, Wang W, Luo H, Bao S, Searchfield G, Zhang J (2021) Neuroinflammation and tinnitus. Behav Neurosci Tinnitus 161\u201374. https:\/\/doi.org\/10.1007\/7854_2021_238","DOI":"10.1007\/7854_2021_238"},{"key":"5556_CR44","doi-asserted-by":"publisher","first-page":"108002","DOI":"10.1016\/j.heares.2020.108002","volume":"402","author":"S Someya","year":"2021","unstructured":"Someya S, Kim MJ (2021) Cochlear detoxification: role of alpha class glutathione transferases in protection against oxidative lipid damage, ototoxicity, and cochlear aging. Hear Res 402:108002. https:\/\/doi.org\/10.1016\/j.heares.2020.108002","journal-title":"Hear Res"},{"key":"5556_CR45","unstructured":"US Food and Drug Administration (2026a) FDA Adverse Event Reporting System (FAERS) Public Dashboard [Internet]. Silver Spring (MD): FDA; c2026. Available from: https:\/\/fis.fda.gov\/sense\/app\/95239e26-e0be-42d9-a960-9a5f7f1c25ee\/sheet\/7a47a261-d58b-4203-a8aa-6d3021737452\/state\/analysis.\u00a0Accessed 19 Feb 2026"},{"key":"5556_CR46","unstructured":"US Food and Drug Administration (2026b) DailyMed: current labelling information [Internet]. Bethesda (MD): National Library of Medicine; c2026 [cited 2026 May 5]. Labels reviewed: lovastatin (NDA 019922); terazosin hydrochloride (NDA 019782); guselkumab (BLA 761061); lifitegrast (NDA 208073). Available from: https:\/\/dailymed.nlm.nih.gov.\u00a0Accessed 19 Feb 2026"},{"issue":"12","key":"5556_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2024.0380","volume":"85","author":"L Wang","year":"2024","unstructured":"Wang L, Tang Y, Zhuge P (2024) Analysis of drug-related tinnitus based on the FDA adverse event reporting system database. Br J Hosp Med 85(12):1\u20132. https:\/\/doi.org\/10.12968\/hmed.2024.0380","journal-title":"Br J Hosp Med"},{"key":"5556_CR48","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology (2024) ATC classification index with DDDs. Oslo: WHOCC\/NIPH. Available from: https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/atc-classification.\u00a0Accessed 21 Feb 2026"},{"key":"5556_CR49","doi-asserted-by":"publisher","first-page":"109262","DOI":"10.1016\/j.heares.2025.109262","volume":"461","author":"T Wu","year":"2025","unstructured":"Wu T, Zhao Z, Wang P, Du Q, Shi Y, Zhu B, Dong J, Li D (2025) Drug-induced hearing loss: a real-world pharmacovigilance study using the FDA adverse event reporting system database. Hear Res 461:109262. https:\/\/doi.org\/10.1016\/j.heares.2025.109262","journal-title":"Hear Res"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05556-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05556-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05556-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:12:28Z","timestamp":1789978348000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05556-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5556"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05556-7","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"23 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was based exclusively on secondary analysis of publicly available, de-identified database records and did not involve direct human participant involvement or identifiable personal data. Accordingly, formal approval from an Institutional Review Board (IRB) or Ethics Committee was not required in accordance with applicable institutional and regulatory guidelines.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involved secondary analysis of publicly available, de-identified database records and did not involve direct participation of human subjects or access to identifiable patient information. Therefore, informed consent to participate was not required.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Human ethics and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}